BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
MELVILLE, NY., Sept. 27, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will be participating in the Roth Inaugural Healthcare Opportunities Conference being held at The Yale Club in New York City on October 6, 2022. Company management will also be participating in one-on-one meetings throughout the conference.
Related news for (BRTX)
- BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
- BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
- Today’s Top Performers: MoBot’s Market Review 02/25/25 07:00 PM
- MoBot’s Stock Market Highlights – 02/25/25 06:00 PM
- MoBot’s Stock Market Highlights – 02/20/25 08:00 AM